ProCE Banner Activity

ExpressPoints:
Next-Generation Therapeutics and Contemporary Management of Myelofibrosis

Slideset Download
Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in managing patients with MF.

Released: December 16, 2022

Expiration: December 15, 2023

No longer available for credit.

Share

Faculty

Srdan Verstovsek

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Brady L. Stein

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Abdulraheem Yacoub

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

AbbVie Inc.

CTI BioPharma Corp

Program Director Disclosure

Program Director

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Faculty Disclosure

Primary Author

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas